经尿道等离子剜除术治疗巨大良性前列腺增生的疗效观察

目的 探讨经尿道等离子剜除术治疗巨大良性前列腺增生的疗效.方法 将2011年1月至2015年12月我科收治的65例巨大前列腺增生患者随机分为两组,分别应用经尿道前列腺等离子剜除术(33例)和经尿道等离子体前列腺电切术(32例)进行治疗,对比两组的相关临床指标.结果 与经尿道等离子体前列腺电切术组相比,经尿道前列腺等离子剜除术组的手术时间明显缩短(P<0.05),术中冲洗液量和术后血红蛋白水平下降值亦明显低于经尿道等离子体前列腺电切术组(P<0.05);术后复查,经尿道前列腺等离子剜除术组的最大尿流率明显高于经尿道等离子体前列腺电切术组(P<0.05),残余尿量明显低于经尿道等离子体前列腺电切术组(P<0.05).结论 对于巨大前列腺增生,与经尿道等离子体前列腺电切术比较,经尿道前列腺等离子剜除术的优势更明显,能更完全地切除腺体,缩短手术时间,降低术中出血量,值得临床推广应用.

Efficacy of transurethral enucleation resection of prostate in treatment of huge benign prostatic hyperplasia

Objective To investigate the efficacy of transurethral enucleation resection of prostate for treatment of huge benign prostatic hyperplasia (BPH).Methods Patients with BPH were randomly divided into two groups: 33 cases underwent transurethral plasmakinetic enucleation (TUKEP) and 32 cases underwent transurethral plasmakinetic resection (TUPKP).The efficacy, maximum urinary flow (Qmax) and postvoiding residual volume (PVR) were compared between the two groups.Results Compared with TUPKP group, TUKEP group operation time was significantly shorter (P<0.05), fluid volume and hemoglobin levels decreased significantly lower (P<0.05);after review the Qmax of TUKEP group was significantly higher than TUPKP group (P<0.05), PVR was significantly lower than TUPKP group (P<0.05), TUKEP group hospital stay and hospital costs were significantly lower than TUPKP group (P<0.05).Conclusions TUKEP has more advantage than TUPKP in the treatment of huge BPH, TUKEP can remove the gland completely, shorten the operation time and reduce blood loss which was worthy of clinical application.